American Century Companies’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-71,165
| Closed | -$364K | – | 2885 |
|
2024
Q3 | $364K | Buy |
71,165
+25,603
| +56% | +$131K | ﹤0.01% | 2577 |
|
2024
Q2 | $165K | Buy |
45,562
+7,039
| +18% | +$25.5K | ﹤0.01% | 2762 |
|
2024
Q1 | $124K | Sell |
38,523
-782,914
| -95% | -$2.51M | ﹤0.01% | 2840 |
|
2023
Q4 | $4.03M | Sell |
821,437
-2,881
| -0.3% | -$14.1K | ﹤0.01% | 1468 |
|
2023
Q3 | $4.49M | Buy |
824,318
+86,478
| +12% | +$471K | ﹤0.01% | 1371 |
|
2023
Q2 | $4.95M | Buy |
737,840
+70
| +0% | +$470 | ﹤0.01% | 1317 |
|
2023
Q1 | $6.51M | Buy |
737,770
+159,372
| +28% | +$1.41M | 0.01% | 1168 |
|
2022
Q4 | $4.42M | Buy |
578,398
+176,441
| +44% | +$1.35M | ﹤0.01% | 1267 |
|
2022
Q3 | $2.86M | Buy |
401,957
+220,266
| +121% | +$1.57M | ﹤0.01% | 1311 |
|
2022
Q2 | $1.47M | Buy |
181,691
+2,065
| +1% | +$16.7K | ﹤0.01% | 1533 |
|
2022
Q1 | $2.49M | Sell |
179,626
-1,878
| -1% | -$26.1K | ﹤0.01% | 1335 |
|
2021
Q4 | $5.09M | Buy |
181,504
+57,642
| +47% | +$1.62M | ﹤0.01% | 1051 |
|
2021
Q3 | $4.21M | Buy |
123,862
+142
| +0.1% | +$4.83K | ﹤0.01% | 1074 |
|
2021
Q2 | $5.06M | Buy |
+123,720
| New | +$5.06M | ﹤0.01% | 988 |
|
2021
Q1 | – | Sell |
-948,837
| Closed | -$56.1M | – | 2195 |
|
2020
Q4 | $56.1M | Sell |
948,837
-48
| -0% | -$2.84K | 0.04% | 372 |
|
2020
Q3 | $46.1M | Buy |
948,885
+147,714
| +18% | +$7.18M | 0.04% | 366 |
|
2020
Q2 | $38.8M | Buy |
+801,171
| New | +$38.8M | 0.04% | 387 |
|
2019
Q3 | – | Sell |
-177,091
| Closed | -$8.55M | – | 1206 |
|
2019
Q2 | $8.55M | Buy |
+177,091
| New | +$8.55M | 0.01% | 665 |
|